Cargando…

Clinical use of Jak 1 inhibitors for rheumatoid arthritis

The uptake of Jak inhibitors in the RA space has been among the most rapid in rheumatology, based on the results of comprehensive clinical trial programmes of five agents. Newer generations of Jak inhibitors, like upadacitinib and filgotinib, target Jak 1 selectively with the aim of maximizing effic...

Descripción completa

Detalles Bibliográficos
Autor principal: Nash, Peter
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8098107/
https://www.ncbi.nlm.nih.gov/pubmed/33950231
http://dx.doi.org/10.1093/rheumatology/keab265